Exact Mass: 620.4652

Exact Mass Matches: 620.4652

Found 51 metabolites which its exact mass value is equals to given mass value 620.4652, within given mass tolerance error 4.0E-5 dalton. Try search metabolite list with more accurate mass tolerance error 8.0E-6 dalton.

Mosinone A

5-(11-hydroxy-11-{5-[(4Z)-1-hydroxypentadec-4-en-1-yl]oxolan-2-yl}-5-oxoundecyl)-3-(2-oxopropyl)oxolan-2-one

C37H64O7 (620.4652)


Mosinone A is found in fruits. Mosinone A is a constituent of Annona squamosa (sugar apple) Constituent of Annona squamosa (sugar apple). Mosinone A is found in fruits.

   

DG(14:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0)

(2S)-1-hydroxy-3-(tetradecanoyloxy)propan-2-yl (5R,6Z,8E,10E,12S,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoate

C37H64O7 (620.4652)


DG(14:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(14:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/14:0/0:0)

(2S)-3-hydroxy-2-(tetradecanoyloxy)propyl (5S,6Z,8E,10E,12R,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoate

C37H64O7 (620.4652)


DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/14:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/14:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(14:0/0:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R))

(2R)-2-hydroxy-3-(tetradecanoyloxy)propyl (5S,6Z,8E,10E,12R,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoate

C37H64O7 (620.4652)


DG(14:0/0:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0/14:0)

(2S)-2-Hydroxy-3-(tetradecanoyloxy)propyl (5S,6Z,8E,12R,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoic acid

C37H64O7 (620.4652)


DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0/14:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-14:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0)

(2S)-1-Hydroxy-3-[(12-methyltridecanoyl)oxy]propan-2-yl (5R,6Z,8E,10E,12S,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoic acid

C37H64O7 (620.4652)


DG(i-14:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-14:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/i-14:0/0:0)

(2S)-3-Hydroxy-2-[(12-methyltridecanoyl)oxy]propyl (5S,6Z,8E,10E,12R,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoic acid

C37H64O7 (620.4652)


DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/i-14:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/i-14:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-14:0/0:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R))

(2R)-2-Hydroxy-3-[(12-methyltridecanoyl)oxy]propyl (5S,6Z,8E,10E,12R,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoic acid

C37H64O7 (620.4652)


DG(i-14:0/0:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0/i-14:0)

(2S)-2-Hydroxy-3-[(12-methyltridecanoyl)oxy]propyl (5S,6Z,8E,10E,12R,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoic acid

C37H64O7 (620.4652)


DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0/i-14:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-14:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0)

(2S)-1-hydroxy-3-[(12-methyltridecanoyl)oxy]propan-2-yl (5S,6E,8Z,11Z,13E,15R)-5,15-dihydroxyicosa-6,8,11,13-tetraenoate

C37H64O7 (620.4652)


DG(i-14:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-14:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/i-14:0/0:0)

(2S)-3-Hydroxy-2-[(12-methyltridecanoyl)oxy]propyl (5R,6E,8Z,11Z,15S)-5,15-dihydroxyicosa-6,8,11,13-tetraenoic acid

C37H64O7 (620.4652)


DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/i-14:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/i-14:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-14:0/0:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S))

(2R)-2-Hydroxy-3-[(12-methyltridecanoyl)oxy]propyl (5R,6E,8Z,11Z,15S)-5,15-dihydroxyicosa-6,8,11,13-tetraenoic acid

C37H64O7 (620.4652)


DG(i-14:0/0:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0/i-14:0)

(2S)-2-hydroxy-3-[(12-methyltridecanoyl)oxy]propyl (5R,6E,8Z,11Z,13E,15S)-5,15-dihydroxyicosa-6,8,11,13-tetraenoate

C37H64O7 (620.4652)


DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0/i-14:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-14:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0)

(2S)-1-Hydroxy-3-[(12-methyltridecanoyl)oxy]propan-2-yl (5R,6R,8Z,11Z,14Z,17Z)-5,6-dihydroxyicosa-8,11,14,17-tetraenoic acid

C37H64O7 (620.4652)


DG(i-14:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-14:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/i-14:0/0:0)

(2S)-3-Hydroxy-2-[(12-methyltridecanoyl)oxy]propyl (5S,6S,8Z,11Z,14Z,17Z)-5,6-dihydroxyicosa-8,11,14,17-tetraenoic acid

C37H64O7 (620.4652)


DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/i-14:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/i-14:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-14:0/0:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R))

(2R)-2-Hydroxy-3-[(12-methyltridecanoyl)oxy]propyl (5S,6S,8Z,11Z,14Z,17Z)-5,6-dihydroxyicosa-8,11,14,17-tetraenoic acid

C37H64O7 (620.4652)


DG(i-14:0/0:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0/i-14:0)

(2S)-2-Hydroxy-3-[(12-methyltridecanoyl)oxy]propyl (5S,6S,8Z,11Z,14Z,17Z)-5,6-dihydroxyicosa-8,11,14,17-tetraenoic acid

C37H64O7 (620.4652)


DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0/i-14:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   
   
   
   
   

3-[13-Hydroxy-13-[[5-(1-hydroxy-5-oxoundecyl)octahydro-2,2-bifuran]-5-yl]tridecyl]-5-methylfuran-2(5H)-one

3-[13-Hydroxy-13-[[5-(1-hydroxy-5-oxoundecyl)octahydro-2,2-bifuran]-5-yl]tridecyl]-5-methylfuran-2(5H)-one

C37H64O7 (620.4652)


   
   

Mosinone A

5-(11-hydroxy-11-{5-[(4Z)-1-hydroxypentadec-4-en-1-yl]oxolan-2-yl}-5-oxoundecyl)-3-(2-oxopropyl)oxolan-2-one

C37H64O7 (620.4652)


   

DG(14:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0)

DG(14:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0)

C37H64O7 (620.4652)


   

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/14:0/0:0)

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/14:0/0:0)

C37H64O7 (620.4652)


   

DG(14:0/0:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R))

DG(14:0/0:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R))

C37H64O7 (620.4652)


   

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0/14:0)

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0/14:0)

C37H64O7 (620.4652)


   

DG(i-14:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0)

DG(i-14:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0)

C37H64O7 (620.4652)


   

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/i-14:0/0:0)

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/i-14:0/0:0)

C37H64O7 (620.4652)


   

DG(i-14:0/0:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R))

DG(i-14:0/0:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R))

C37H64O7 (620.4652)


   

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0/i-14:0)

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0/i-14:0)

C37H64O7 (620.4652)


   

DG(i-14:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0)

DG(i-14:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0)

C37H64O7 (620.4652)


   

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/i-14:0/0:0)

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/i-14:0/0:0)

C37H64O7 (620.4652)


   

DG(i-14:0/0:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S))

DG(i-14:0/0:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S))

C37H64O7 (620.4652)


   

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0/i-14:0)

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0/i-14:0)

C37H64O7 (620.4652)


   

DG(i-14:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0)

DG(i-14:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0)

C37H64O7 (620.4652)


   

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/i-14:0/0:0)

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/i-14:0/0:0)

C37H64O7 (620.4652)


   

DG(i-14:0/0:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R))

DG(i-14:0/0:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R))

C37H64O7 (620.4652)


   

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0/i-14:0)

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0/i-14:0)

C37H64O7 (620.4652)


   

(3r,5r)-5-[(11r)-11-hydroxy-11-[(2r,5r)-5-[(1r,4z)-1-hydroxypentadec-4-en-1-yl]oxolan-2-yl]-5-oxoundecyl]-3-(2-oxopropyl)oxolan-2-one

(3r,5r)-5-[(11r)-11-hydroxy-11-[(2r,5r)-5-[(1r,4z)-1-hydroxypentadec-4-en-1-yl]oxolan-2-yl]-5-oxoundecyl]-3-(2-oxopropyl)oxolan-2-one

C37H64O7 (620.4652)


   

3-{13-hydroxy-13-[5'-(1-hydroxy-5-oxoundecyl)-[2,2'-bioxolan]-5-yl]tridecyl}-5-methyl-5h-furan-2-one

3-{13-hydroxy-13-[5'-(1-hydroxy-5-oxoundecyl)-[2,2'-bioxolan]-5-yl]tridecyl}-5-methyl-5h-furan-2-one

C37H64O7 (620.4652)


   

3-{13-hydroxy-13-[5'-(1-hydroxyundecyl)-[2,2'-bioxolan]-5-yl]-3-oxotridecyl}-5-methyl-5h-furan-2-one

3-{13-hydroxy-13-[5'-(1-hydroxyundecyl)-[2,2'-bioxolan]-5-yl]-3-oxotridecyl}-5-methyl-5h-furan-2-one

C37H64O7 (620.4652)


   

(5s)-3-[(2r)-2-hydroxy-7-[(2r,2'r,5s,5'r)-5'-[(2r,5r)-5-[(1r)-1-hydroxytridecyl]oxolan-2-yl]-[2,2'-bioxolan]-5-yl]heptyl]-5-methyl-5h-furan-2-one

(5s)-3-[(2r)-2-hydroxy-7-[(2r,2'r,5s,5'r)-5'-[(2r,5r)-5-[(1r)-1-hydroxytridecyl]oxolan-2-yl]-[2,2'-bioxolan]-5-yl]heptyl]-5-methyl-5h-furan-2-one

C37H64O7 (620.4652)


   

(5s)-3-[(13r)-13-hydroxy-13-[(2r,2'r,5r,5'r)-5'-[(1s)-1-hydroxyundecyl]-[2,2'-bioxolan]-5-yl]-8-oxotridecyl]-5-methyl-5h-furan-2-one

(5s)-3-[(13r)-13-hydroxy-13-[(2r,2'r,5r,5'r)-5'-[(1s)-1-hydroxyundecyl]-[2,2'-bioxolan]-5-yl]-8-oxotridecyl]-5-methyl-5h-furan-2-one

C37H64O7 (620.4652)


   

3-(2-hydroxy-7-{5'-[5-(1-hydroxytridecyl)oxolan-2-yl]-[2,2'-bioxolan]-5-yl}heptyl)-5-methyl-5h-furan-2-one

3-(2-hydroxy-7-{5'-[5-(1-hydroxytridecyl)oxolan-2-yl]-[2,2'-bioxolan]-5-yl}heptyl)-5-methyl-5h-furan-2-one

C37H64O7 (620.4652)


   

(5s)-3-{[(2r,5r)-5-[(8r)-8-hydroxy-8-[(2r,5r)-5-[(1r)-1-hydroxypentadecyl]oxolan-2-yl]-2-oxooctyl]oxolan-2-yl]methyl}-5-methyl-5h-furan-2-one

(5s)-3-{[(2r,5r)-5-[(8r)-8-hydroxy-8-[(2r,5r)-5-[(1r)-1-hydroxypentadecyl]oxolan-2-yl]-2-oxooctyl]oxolan-2-yl]methyl}-5-methyl-5h-furan-2-one

C37H64O7 (620.4652)


   

(5s)-3-{[(2s,5r)-5-[(8r)-8-hydroxy-8-[(2r,5r)-5-[(1r)-1-hydroxypentadecyl]oxolan-2-yl]-2-oxooctyl]oxolan-2-yl]methyl}-5-methyl-5h-furan-2-one

(5s)-3-{[(2s,5r)-5-[(8r)-8-hydroxy-8-[(2r,5r)-5-[(1r)-1-hydroxypentadecyl]oxolan-2-yl]-2-oxooctyl]oxolan-2-yl]methyl}-5-methyl-5h-furan-2-one

C37H64O7 (620.4652)


   

(5r)-3-[(13r)-13-hydroxy-13-[(2s,2'r,5s,5's)-5'-[(1s)-1-hydroxy-5-oxoundecyl]-[2,2'-bioxolan]-5-yl]tridecyl]-5-methyl-5h-furan-2-one

(5r)-3-[(13r)-13-hydroxy-13-[(2s,2'r,5s,5's)-5'-[(1s)-1-hydroxy-5-oxoundecyl]-[2,2'-bioxolan]-5-yl]tridecyl]-5-methyl-5h-furan-2-one

C37H64O7 (620.4652)


   

3-[(5-{8-hydroxy-8-[5-(1-hydroxypentadecyl)oxolan-2-yl]-2-oxooctyl}oxolan-2-yl)methyl]-5-methyl-5h-furan-2-one

3-[(5-{8-hydroxy-8-[5-(1-hydroxypentadecyl)oxolan-2-yl]-2-oxooctyl}oxolan-2-yl)methyl]-5-methyl-5h-furan-2-one

C37H64O7 (620.4652)


   

(5s)-3-[(13r)-13-hydroxy-13-[(2r,2'r,5s,5's)-5'-[(1s)-1-hydroxyundecyl]-[2,2'-bioxolan]-5-yl]-3-oxotridecyl]-5-methyl-5h-furan-2-one

(5s)-3-[(13r)-13-hydroxy-13-[(2r,2'r,5s,5's)-5'-[(1s)-1-hydroxyundecyl]-[2,2'-bioxolan]-5-yl]-3-oxotridecyl]-5-methyl-5h-furan-2-one

C37H64O7 (620.4652)